Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 May 5.

Published in final edited form as: Blood. 1999 Nov 15;94(10):3349–3357.

Table 3.

Vector Expression in 2°CFU-S

Primary Recipient No.^*	MNDeGFPSN			LeGFPSN
Primary Recipient No.^*	Expression in 1° BM	Vector^† (n)	Expression^‡	Expression in 1° BM	Vector^† (n)	Expression^‡
1 (8 wks)	60%	13/13 (3)	13/13	0.4%	13/15 (4)	0/13
2 (6 mos)	78.5%	6/6 (2)	6/6	ND	ND	ND
3 (4 mos)	65.1%	8/8 (3)	8/8	8.4%	8/12 (3)	0/8
4 (6 mos)	84.1%	11/11 (4)	11/11	4.4%	12/16 (4)	0/12
5 (6 mos)	40.5%	16/16 (4)	16/16	31%	13/13 (4)	0/13
1-5		54/54	54/54		46/56	0/46
		100%	100%		82%	0%

Abbreviation: (n), number of secondary transplant recipients; ND, not done.

^*

Time after 1° transplant when 2° transplant was performed.

^†

Number of CFU-S PCR(+) for vector DNA/number of CFU-S tested.

^‡

Number of CFU-S (+) for eGFP expression by FACS/number of CFU-S tested.